Noted molecular biologist James Bliska, PhD, is joining the Geisel School of Medicine at Dartmouth as a Distinguished Professor in Microbiology and Immunology and senior lead faculty member of the Personalized Treatments for Cystic Fibrosis (CF) Cluster, a cross-Dartmouth group of investigators established to develop innovative, personalized medicine and treatments for CF and lung infections caused by opportunistic pathogens.
Sandra L. Wong, MD, MS, chair of surgery at the Geisel School of Medicine and Dartmouth-Hitchcock, has been named the William N. and Bessie Allyn Professor in Surgery.
A Dartmouth-led study found that social media big data can be used to understand communication and behavioral patterns related to prescription drug abuse.
Geisel School of Medicine Dean Duane Compton, PhD, announced today that Gregory Ogrinc, MD, MS, an internationally recognized innovator in medical education, has been name the Senior Associate Dean for Medical Education, a role that he has served in on an interim basis since 2014.
Dartmouth’s Graduate Program in Quantitative Biomedical Sciences (QBS) is offering a new master’s degree with a concentration in health data science beginning in fall 2018.
A team of Geisel researchers will receive funding from the Patient-Centered Outcomes Research Institute (PCORI) to design new methods for comparing the effectiveness of alternative therapies that can lead to improvements in practice and better outcomes for patients.
Geisel researchers take a close look at New Hampshire’s complex opioid epidemic, and one city’s novel response.
Dartmouth-led research is in early phase drug discovery and finds promising therapeutic leads after targeting vulnerabilities in nervous system tumors, including glioblastoma.
A team of Dartmouth researchers has found that mothers who have developed antibodies against the herpes simplex virus (HSV-1) can pass these antibodies to the nervous systems of their infants, protecting them from acquiring the virus.
A new study by researchers at Dartmouth has found that adolescents living in medical marijuana states with a plethora of dispensaries are more likely to have tried new methods of cannabis use, such as edibles and vaping, at a younger age than those living in states with fewer dispensaries.